Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 4, 2011, Pages 823-828

  Dönmez, Yaprak ^a   Akhmetova, Laila ^a   İşeri, Özlem Darcansoy ^b   Kars, Meltem Demirel ^a   Gündüz, Ufuk ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

MCF 7; MDR reversal; Promethazine; Verapamil

Indexed keywords

DOXORUBICIN; PROMETHAZINE; VERAPAMIL;

ARTICLE; BREAST CARCINOMA; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG MECHANISM; DRUG TRANSPORT; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MDR1 GENE; MRP1 GENE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 79954447132     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1385-y     Document Type: Article

References (29)

1. S Ambudkar C Kimchi-Sarfaty Z Sauna M Gottesman 2003 P-glycoprotein: from genomics to mechanism Oncogene 22 7468 7485 14576852 10.1038/sj.onc.1206948 1:CAS:528:DC%2BD3sXotlaju70%3D (Pubitemid 37487170)
2. S Anuchapreeda P Leechanachai MM Smith SV Ambudkar PN Limtrakul 2002 Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells Biochem Pharmacol 64 573 582 12167476 10.1016/S0006-2952(02)01224-8 1:CAS:528:DC%2BD38XmtVWls7g%3D
3. R Callaghan A Stafford RM Epand 1993 Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties Biochim Biophys Acta 1175 277 282 8435444 10.1016/0167-4889(93)90217-D 1:CAS:528:DyaK3sXhvVaru7w%3D (Pubitemid 23054313)
4. WS Dalton 1997 Mechanisms of drug resistance in hematologic malignancies Semin Hematol 34 3 8 9408955 1:STN:280:DyaK1c%2Fntlejsg%3D%3D (Pubitemid 28032414)
5. S Drori GD Eytan YG Assaraf 1995 Potentiation of anticancer drug cytotoxicity by multidrug resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability Eur J Biochem 228 1020 1029 7737146 10.1111/j.1432-1033.1995.tb20352.x 1:CAS:528: DyaK2MXksl2qtbc%3D
6. U Eskiocak ÖD İşeri MD Kars A Biçer U Gündüz 2008 Effect of doxorubicin on telomerase activity and apoptotic gene expression in doxorubicin resistant and sensitive MCF-7 cells Chemotherapy 54 209 216 18560228 10.1159/000140464 1:CAS:528:DC%2BD1cXnvFeiurw%3D (Pubitemid 351929272)
7. MM Gottesman T Fojo SE Bates 2002 Multidrug resistance in cancer: role of ATP-dependent transporters Nat Rev Cancer 2 1 48 58 11902585 10.1038/nrc706 1:CAS:528:DC%2BD38XhvF2jtL8%3D (Pubitemid 37328807)
8. A Hilgeroth A Molnár J Molnár B Voigt 2006 Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal properties Eur J Med Chem 41 548 551 16516350 10.1016/j.ejmech.2005.11. 011 1:CAS:528:DC%2BD28Xkt1yjtr4%3D
9. ÖD İşeri MD Kars S Eroǧlu U Gündüz 2009 Cross-resistance development and combined applications of anticancer agents in drug resistant MCF-7 cell lines Int J Hem Oncol 1 19 1 8
10. MD Kars OD Işeri U Gündüz AU Ural F Arpaci J Molnar 2006 Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds Anticancer Res 26 4559 4568 17201178 1:CAS:528:DC%2BD2sXpslGhtg%3D%3D (Pubitemid 46031531)
11. MD Kars OD Iseri U Gunduz J Molnar 2008 Reversal of MDR by synthetic and natural compounds in drug resistant MCF-7 cell lines Chemotherapy 54 194 200 18560226 10.1159/000140462 1:CAS:528:DC%2BD1cXnvFeiur4%3D (Pubitemid 351929270)
12. Kars MD, Iseri ÖD, Ural AU, Avcu F, Beyzadeoglu M, Dirican B, Gündüz U (2009) Development of radioresistance in drug resistant human MCF-7 breast cancer cells. J Radiol Pract. doi: 10.1017/S1460396909990070
13. GD Kruh MG Belinsky 2003 The MRP family of drug efflux pumps Oncogene 22 7537 7552 14576857 10.1038/sj.onc.1206953 1:CAS:528:DC%2BD3sXotlaju7Y%3D (Pubitemid 37487175)
14. T Litman TE Druley WD Stein SE Bates 2001 From MDR to MXR: new understanding of multidrugresistance systems, their properties and clinical significance CMLS Cell Mol Life Sci 58 931 959 10.1007/PL00000912 1:CAS:528:DC%2BD3MXlvFSms74%3D (Pubitemid 32652819)
15. -ΔC T method Methods 25 402 408 11846609 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D (Pubitemid 34164012)
16. K Michalak O Wesołowska N Motohashi AB Hendrich 2007 The role of the membrane actions of phenothiazines and flavonoids as functional modulators Top Heterocycl Chem 8 223 302 10.1007/7081-2007-054 1:CAS:528: DC%2BD1cXjsVenug%3D%3D
17. J Molnar N Gyémánt M Tanaka J Hohmann E Bergmann-Leitner P Molnár J Deli R Didiziapetris M-JU Ferreira 2006 Inhibition of multidrug resistance of cancer cells by natural diterpens, triterpenes and carotenoids Curr Pharm Design 12 287 311 10.2174/138161206775201893 1:CAS:528: DC%2BD28XitlCruw%3D%3D
18. J Molnar D Szabo Y Mandi I Mucsi J Fischer A Varga S Konig N Motohashi 1998 Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds Anticancer Res 18 3033 3038 9713505 1:CAS:528:DyaK1cXlsF2qt78%3D (Pubitemid 28388811)
19. N Motohashi T Kurihara H Wakabayashi M Yaji I Mucsi J Molnar S Maruyama H Sakagami H Nakashima S Tani Y Shirataki M Kawase 2001 Biological activity of a fruit vegetable, "Anastasia green", a species of sweet pepper In Vivo 5 437 442 (Pubitemid 33039977)
20. C Muller F Goubin E Ferrandis I Cornil-Scharwtz JD Bailly C Bordier J Bénard BI Sikic G Laurent 1995 Evidence for transcriptional control of human MDR1 gene expression by verapamil in multidrug-resistant leukemic cells Mol Pharmacol 47 1 51 56 7838133 1:CAS:528:DyaK2MXjsVSntb0%3D
21. K Mutoh S Tsukahara J Mitsuhashi K Katayama Y Sugimoto 2006 Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells Cancer Sci 97 1198 1204 16925584 10.1111/j.1349-7006.2006.00300.x 1:CAS:528:DC%2BD28XhtFemtbnP (Pubitemid 44430645)
22. S Nobili I Landini B Giglioni E Mini 2006 Pharmacological strategies for overcoming multidrug resistance Curr Drug Targets 7 7 861 879 16842217 10.2174/138945006777709593 1:CAS:528:DC%2BD28Xms1Crsrk%3D
23. I Pajeva M Wiese 1998 Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study J Med Chem 41 1815 1826 9599232 10.1021/jm970786k 1:CAS:528: DyaK1cXis12qu7k%3D (Pubitemid 28248657)
24. E Perez 2009 Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer Breast Can Res Treat 114 195 201 10.1007/s10549-008-0005-6 1:CAS:528: DC%2BD1MXhsFWnu7o%3D
25. H Schuldes J Dolderer L Knobloch S Bade R Bickeboeller BG Woodcock D Jonas G Zimmer 1998 Relationship between plasma membrane fluidity and R-verapamil action in CHO cells Int J Clin Pharmacol Ther 36 71 73 9520147 1:CAS:528:DyaK1cXovFGlsA%3D%3D (Pubitemid 28059630)
26. B Trock F Leonessa R Clarke 1997 Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance J Nat Can Inst 89 917 931 10.1093/jnci/89.13.917 1:STN:280:DyaK2szlslensA%3D%3D (Pubitemid 27282064)
27. AM Young CE Allen KL Audus 2003 Efflux transporters of the human placenta Adv Drug Deliver Rev 55 125 132 10.1016/S0169-409X(02)00174-6 1:CAS:528:DC%2BD3sXivVWnug%3D%3D (Pubitemid 36078454)
28. ST Yu TM Chen SY Tseng YH Chen 2007 Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells Biochem Biophys Res Commun 358 79 84 17482571 10.1016/j.bbrc.2007.04.107 1:CAS:528: DC%2BD2sXlt1ertLY%3D (Pubitemid 46719083)
29. YG Zhou KY Li HD Li 2008 Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells Eur J Clin Pharmacol 64 7 697 703 18478216 10.1007/s00228-008-0487-5 1:CAS:528: DC%2BD1cXmtlSjsr0%3D